Our people

Dr O’Rourke joined us in 2018, having worked as a research associate within UCL on several diverse life science / pharmaceutical research projects covering the areas of tissue engineering, drug delivery, regenerative medicine, biomaterials and stem cell biology.

Caitriona holds a PhD in tissue engineering from the Open University and a MSc in neuropharmacology from the National University of Galway, Ireland. Read more about Dr. Caitriona O'Rourke (Away from office)

Chloë has worked as a strategic communications advisor at global PR and communications agencies for the last five years, supporting clients in the science and innovation, technology and energy sectors.

She brings more than 10 years experience in CMS management, social media strategy and content creation, and a personal interest in web development and online visibility in search engines and LLMs. Read more about Chloë Howard

Dr Panaretou is responsible for market analysis, technology and deal assessment and project valuations, including valuations for licence and spinout transactions.

Prior to joining UCL Ventures, Christina was a business analyst at the Bloomsbury Bioseed Fund, a University Challenge Seed Fund that specialised in early-stage life science investments; there she was responsible for identifying and performing due diligence on investment opportunities and assisting in contract negotiations.

She holds a BSc in biochemistry from UCL and gained a PhD at the former London branch of the Ludwig Institute for Cancer Research, focusing on cell biology and intracellular signalling. This was followed by postdoctoral research at the Imperial Cancer Research Fund (now CRUK). Read more about Dr Christina Panaretou

Dr Madla Angeles supports the translation of cutting-edge research into high-impact social ventures. She works across a diverse portfolio spanning women’s health technologies, digital education platforms, sustainable solutions, and patient-centred innovations originating from world-leading UCL research, driving both commercial success and scalable societal impact.

Christine holds a PhD in Pharmaceutics from the UCL School of Pharmacy, where her research focused on sex differences in oral drug absorption from pharmaceutical formulations.

She is the founder of Sex in Science, an initiative dedicated to addressing the persistent sex and gender gap in healthcare research.

Christine has consulted for leading pharmaceutical companies on the integration of sex as a biological variable in preclinical and clinical trial design, helping to advance more equitable and effective healthcare outcomes. Read more about Dr. Christine Madla Angeles

Dr. Bertoli is part of the BioPharm team and is a co-located and co-funded cancer specialist representing the joint interests of UCL Ventures and Cancer Research UK (50:50).

For UCL Ventures she is primarily responsible for IP protection and commercialisation of technologies developed at UCL Hospitals NHS Foundation Trust. For Cancer Research UK she is a Search and Evaluation Manager, responsible for identifying and facilitating the translation of UCL-based research into clinically-meaningful products for the benefit of cancer patients.

Cosetta joined us from Cancer Research Horizons, where she was Translation Executive in the Search and Evaluation team in the London region, providing intellectual property and translational funding for CRUK-funded projects at Queen Mary University of London, Imperial College London and King's College London. Before that she was project leader in the CRUK Centre for Drug Development, working on early phase clinical trials in oncology.

She has a PhD in Biomedical Sciences and Technologies and extensive research experience in cellular and molecular biology both in the academic sector in Trieste (Italy) and at UCL, and in the private sector where she was leading a team carrying on preclinical work in drug development in oncology. Read more about Dr. Cosetta Bertoli

Dahlia has over five years’ experience in human resources and people operations. Throughout her career, she has taken the lead on recruitment, onboarding, policy management, and staff development. Dahlia is incredibly passionate about improving people processes and creating an ideal employee experience. She holds an MSc in Human Resource Management and is CIPD qualified. Read more about Dahlia Muana

David is a molecular geneticist and virologist by background and has worked managing and licensing intellectual property for over 20 years.

He has twice worked for the University of Oxford’s technology transfer office, where he was involved in technologies as diverse as novel anti-cancer agents and software for medical imaging and scanning. He has also spent considerable time in industry, working for multinationals such as GlaxoSmithKline and Mercury Pharma, through to small university-based start-up companies.

David is responsible for commercialisation opportunities arising from the Institute of Child Health at Great Ormond Street Hospital, the UCL Cancer Institute and the Institute of Cardiovascular Science. Read more about David Philips

Dennis' main responsibilities are to monitor the ongoing financial obligations of complete agreements, and to ensure that all key information is recorded and actioned appropriately post deal. He works closely with Business Managers and the Finance team.

Prior to UCL Ventures, which he joined in 2022, Dennis worked for a regulator, and has experience in the healthcare recruitment industry. Read more about Dennis Bonsu

Dylan leads our IT function